In this study, rats in the model group showed significantly increased Keap1 expression and decreased Nrf2 and HO-1 expression, indicating weakened anti-inflammatory and antioxidant capacity in NAFLD rats. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatotic liver disease.